BBus (QUEENSLAND UNIVERSITY OF TECHNOLOGY)
Ross Dobinson has extensive corporate advisory and investment banking experience. He has also taken an entrepreneurial role in the commercialisation of technologies in a range of fields, including: agricultural science, pharmaceuticals, environmentally-friendly packaging, medical devices, drug delivery technology and nutriceuticals. Mr Dobinson has experience in company formation, seed, mezzanine and IPO funding, specialising in the life sciences sector, where he has been a founding director, investor and executive of listed and unlisted companies.
Commencing as a chartered accountant with Hungerfords, Mr Dobinson has held positions as a Director of the listed stockbroking firm of Jacksons Limited, Head of Corporate Advisory Services at the stockbroking firm operated by National Australia Bank Limited (A.C. Goode & Co. Ltd), Director of National Australia Corporate Advisory Limited, and Director of Corporate Advisory of Dresdner Australia Proprietary Limited.
Mr Dobinson has taken two highly successful biotechnology companies from pre-seed stage to listed status with a current market capitalisation of $1.2 billion. In addition, he has been involved in venture capital initiatives in Australia, Europe and the United States.
Mr Dobinson is currently Chairman of Acrux Limited, Micronix Pty Ltd, Diagnotech Pty Ltd, Farm By Nature Pty Ltd and TPI Enterprises Ltd. He is also a Director of Starpharma Holdings Limited, Origin Capital Limited, PharmaQest Pty Ltd, Healthfarm Fine Foods Pty Ltd and Racing Victoria Limited.
Mr Dobinson was appointed Executive Chairman of the Company on 21 July 2010.
Professor Marilyn A Anderson
BSc (Hons) (The University of Melbourne), PhD (La Trobe University)
Executive Director, Chief Science Officer
Professor Marilyn Anderson is a founding scientist of Hexima. She has over 30 years experience in scientific research in the area of plant biochemistry and genetics. After completing a BSc Honours at The University of Melbourne and a PhD in Biochemistry at La Trobe University, Professor Anderson spent seven years in the United States working on diabetes at the University of Miami and oncogenes at Cold Spring Harbor Laboratory.
She is a Professor of Biochemistry at La Trobe University and an Associate Professorial Fellow in the Botany School at The University of Melbourne. She was appointed Hexima’s Chief Science Officer in July 2009. Professor Anderson was a director at South East Water Limited for over 10 years prior to her appointment to the board of City West Water in 2008. She is a Fellow of the Australian Academy of Science, of the Australian Academy of Technological Sciences and Engineering and of the Australian Institute of Company Directors.
She was appointed a Director of the company on 23 November 2010.
Dr Nicole van der Weerden
BSc (Hons), PhD (La Trobe University), MBA (MBS)
Head of Technology Commercialisation
Dr Nicole van der Weerden completed her PhD in Biochemistry at La Trobe University in 2007. Her PhD research on the antifungal properties and mechanism of action of plant defensins led to the award of a prestigious Victoria Fellowship in 2006. Since completing her PhD, Nicole has worked for Hexima Limited and has led the gene discovery program for the Pioneer partnership on control of fungal diseases in corn. Nicole has completed an MBA at Melbourne Business School.
BCom(Hons) / BAgrSc(Hons) (The University of Melbourne)
Chief Operating Officer
Elisha joined Hexima in 2006, focusing initially on the Company’s Initial Public Offering before moving into a business development role during Hexima’s major partnering phase. Elisha was appointed Chief Operating Officer and Company Secretary in May 2012. Elisha recently completed a Masters of Commercial Law at the University of Melbourne majoring in intellectual property law and corporate governance.
Prior to joining Hexima, Elisha worked as a market analyst with Landmark, Australia’s largest agricultural inputs company.